IL36G and chronic obstructive pulmonary disease: Since glucocorticosteroids are often given as an antiinflammatory treatment to many COPD subjects, particularly during viral-induced exacerbations, we examined whether TLR3 induction of IL-36γ was glucocorticosteroid sensitive.